Table 2. Correlation of plasma fibrinogen concentrations with risk factors, haemodynamic parameters and markers of inflammation in patients with PAH, CTEPH and control individuals.
Control | PAH | CTEPH | ||||
---|---|---|---|---|---|---|
Parameter | R | P value | R | P value | R | P value |
Age | 0.817 | 0.002 | 0.158 | 0.273 | 0.068 | 0.650a |
Sex | 0.233 | 0.491 | 0.128 | 0.367 | 0.051 | 0.732a |
WHO FC | 0.638 | 0.362 | −0.006 | 0.967 | 0.172 | 0.247a |
RVSP | −0.081 | 0.897 | 0.373 | 0.189b | ||
mPAP | 0.487 | 0.128 | 0.044 | 0.760 | 0.373 | 0.009a |
RAP | - | - | −0.065 | 0.734 | 0.621 | <0.0001b |
PVR | 0.200 | 0.580 | 0.105 | 0.513 | 0.326 | 0.035a |
CI | −0.766 | 0.445 | −0.178 | 0.272 | −0.322 | 0.033a |
SvO2 | - | - | 0.022 | 0.913 | −0.236 | 0.160a |
6-MWD | - | - | −0.235 | 0.125 | −0.347 | 0.038a |
PaCO2 | −0.150 | 0.810 | −0.201 | 0.279 | −0.331 | 0.040a |
NT-proBNP | 0.821 | 0.045 | −0.136 | 0.442 | 0.492 | 0.002b |
C-reactive protein | 0.480 | 0.160 | 0.712 | <0.001 | 0.492 | 0.0009b |
aPearson correlation coefficient.
bSpearman correlation coefficient.
See text for abbreviations.